Release Date: 20/01/11 09:51 Summary: IV zanamivir - Phase III study commences Price Sensitive: No Download Document 53.46KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago